ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 79

$873K Total Retail Price of All Prescriptions

Rank: 12 out of 79

405 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 13,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 721 713 1 1
NAMENDA 571 571 2 9
DONEPEZIL HCL 558 558 3 8
FUROSEMIDE 470 470 4 4
LISINOPRIL 446 446 5 2
POTASSIUM CHLORIDE 375 375 6 11
AMLODIPINE BESYLATE 370 362 7 6
SIMVASTATIN 297 296 8 3
HYDROCODONE-ACETAMINOPHEN 288 288 S3 9 5
OMEPRAZOLE 246 246 10 7
DIVALPROEX SODIUM 241 241 11 29
METOPROLOL SUCCINATE 237 228 12 23
WARFARIN SODIUM 207 207 13 14
SERTRALINE HCL 187 187 14 16
GABAPENTIN 181 181 15 12
MIRTAZAPINE 164 164 16 15
METOPROLOL TARTRATE 162 162 17 10
METFORMIN HCL 161 161 18 13
TRAMADOL HCL 159 159 19 17
CITALOPRAM HBR 155 155 20 18
LOSARTAN POTASSIUM 150 150 21 35
ATENOLOL 149 149 22 45
NEXIUM 145 145 23 34
CARBIDOPA-LEVODOPA 139 139 24 44
SPIRONOLACTONE 136 136 25 64
HYDROCHLOROTHIAZIDE 134 134 26 22
ESCITALOPRAM OXALATE 123 123 27 25
CLOPIDOGREL 115 115 28 31
MELOXICAM 114 114 29 52
JANUVIA 109 109 30 89
CYMBALTA 102 102 31 27
TRAZODONE HCL 100 100 32 19
AZITHROMYCIN 99 98 33 75
CLONIDINE HCL 93 90 34 49
CARVEDILOL 91 91 35 21
SINGULAIR 91 91 35 108
RISPERIDONE 90 90 37 24
ALLOPURINOL 90 90 37 65
CRESTOR 90 90 37 62
LYRICA 87 87 40 73
RAMIPRIL 86 86 41 47
PLAVIX 85 85 42 46
EXELON 82 82 43 41
TAMSULOSIN HCL 79 79 44 36
ATORVASTATIN CALCIUM 79 79 44 30
GLIPIZIDE 77 77 46 61
PAROXETINE HCL 74 74 47 87
LANTUS 71 71 48 26
AMITRIPTYLINE HCL 70 70 R 49 134
PROMETHAZINE HCL 70 68 R 49 76
DIGOXIN 67 67 51 42
ADVAIR DISKUS 62 62 52 70
LEXAPRO 59 59 53 90
BYSTOLIC 58 58 54 254
LEVOFLOXACIN 57 57 55 68
DIOVAN 56 56 56 56
ALBUTEROL SULFATE 56 55 56 50
CEFUROXIME 55 55 58 153
CYCLOBENZAPRINE HCL 52 52 R 59 95
ABILIFY 52 52 59 74
PREDNISONE 50 50 61 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.